CARE Ratings Ltd
NSE:CARERATING
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
934.95
1 523.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Summary
Q4-2024
In FY '24, CareEdge achieved a 19% growth in consolidated revenue, reaching INR 332 crores, and a 20% increase in PAT to INR 103 crores. The company saw a 10% rise in standalone Q4 revenue to INR 75 crores and a 25% PAT growth to INR 35 crores. With a strategic shift towards non-rating services, now 10% of the business, and the approval of ESG ratings by SEBI, CareEdge is positioning for sustainable growth.
Ladies and gentlemen, good day, and welcome to CARE Ratings Limited Q4 and FY '24 Earnings Conference Call.
This conference call may contain forward-looking statements about the company, which are based on the beliefs and opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performances and involve risks and uncertainties that are difficult to predict. [Operator Instructions]
Please note that this conference is being recorded. I now hand the conference over to Mr. Mehul Pandya, Managing Director and Group CEO. Thank you, and over to you, sir.
Good afternoon, everyone. I hope all of you are doing well. I extend a warm welcome on behalf of the entire CareEdge family to the quarter 4 and FY '24 investors call.
First and foremost, I'd like to thank all the investors for having reposed faith in us and have supported all throughout. Many of you have been kind enough in terms of suggesting to us new areas to focus upon and I deeply value that. I trust that each of you had the opportunity to thoroughly review our quarterly results. Today, we have with us, all my colleagues who are part of the senior management of CareEdge family. I'm interacting with you to provide and in-depth analysis of our company's performance for the past quarter and to address any queries you may have following my initial remarks.
Let me start by talking about the macro economy. Despite facing headwinds from various global stands, the Indian economy showcases remarkable resilience in the past year. We encountered challenges stemming from weakening external demand, geopolitical tensions and weather-related adversities, yet, and at this hurdle our domestic economy stood strong, demonstrating robust growth estimated at a healthy 7.6% in FY '24. This growth was toppled by a buoyant gross fixed capital formation, we surged by 10.2%, largely attributable to the government's focus on capital expenditure. However, we did witness subdued growth in target consumption primarily due to the weather-related uncertainties and slow rural demand recovery. On a positive note, urban demand remains robust and the anticipation of a favorable monsoon augurs well for rural demand recovery in the current fiscal.
In terms of investment, while government-led capital expenditure continue to drive the growth, the private sector CapEx remained sluggish. However, there are promising signs with the manufacturing sector's capacity utilization surpassing the long-term average and higher investment announcements indicating and improving intent to invest. We believe that facilitating private CapEx will be one of the key parameters in policy framework of the future as well.
On the financial front, fundraising for corporate bond issuances increased by 19% to INR 10.2 lakh crore in FY '24, whereas the issuances of commercial papers remained stable at INR 13.8 lakh crores. Bank credit to industries grew by 8.5% in FY '24 compared to 5.6% last year, largely driven by 7% growth in large industries. However, some moderation was witnessed in credit scores to NBFCs and personal loans due to the increased risk weightage for credit disbursement.
Externally, India's current account position remains favorable, supported by healthy performance in services, exports and remittances. We expect improvement in merchandise export this fiscal year and our inclusion in global bond indices is anticipated to bolster foreign portfolio investment inflow.
In conclusion, while the Indian economy stands comfortably compared to its peers, we must remain vigilant of challenges posed by volatile commodity prices and geopolitical uncertainties, by navigating these challenges accurately we can ensure sustained growth.
At CareEdge, we're still ready to confront the challenges ahead with unwavering determination and our commitment to excellence has never been stronger. In order to strengthen our brand presence in the market, we have embarked on an extensive outreach campaign. Our teams in rating, economic and industry research have been tirelessly working to produce high-quality content, resulting in an impressive output of 329 reports in FY '24. These reports cover a wide range of topics from timely updates to invent analysis and help garner acclaim across renown publications. Moreover, our senior management, [ data ] specialists, industry research team, economic experts, and business development leaders actively participated in over 100 knowledge-sharing forums during the fiscal year. This commitment to sharing knowledge and expertise understood our dedication to driving growth and progress within our industry.
In addition to written content, our presence across media platforms has experienced a significant surge over the past year and continues to expand in the current quarter. From our power pack monthly addition of full sights, to engaging blocks and thought provoking [ Oscars ], we are actively disseminating valuable insights to our audience. As we move forward, let us remain steadfast in our pursuit of excellence and innovation. Together, we will continue to elevate CareEdge to new heights of success.
Let me turn now to our business performance. Firstly, I'm happy to share that the Board of Directors has recommended a final dividend of INR 11 per share at a face value of INR 10, which will take the total dividend declared for the year to INR 18 per share. On the performance, on the stand-alone business, which is the India Ratings business, for FY '24, CareEdge reported revenue from operations of INR 283 crores, registering a growth of 14% over FY '23, as the initial ratings business continued to witness strong growth. The FY '24 operating profit stood at INR 128 crores, a growth of 10% over FY '23. The operating profit margin stood at 45%. Our PAT was INR 119 crores, a growth of 15% over FY '23.
I will reiterate that our financial performance should be assessed on an annual basis rather than on a quarter-to-quarter. Nevertheless, for quarter 4 FY '24, the standalone business, revenue from operations stood at INR 75 crores, a growth of 10% over the corresponding quarter 4 of FY '23. The PAT in the quarter stood at INR 35 crores, a healthy growth of 25% over quarter 4 FY '23.
Turning to our consolidated business performance of -- for FY '24, we reported revenue from operations of INR 332 crores, registering a growth of 19% over FY '23. The operating profit margin stood at 34% and FY '24 PAT was at INR 103 crores, a growth of 20% over FY '23. For the quarter 4 consolidated business performance, the revenue from operations stood at INR 90 crores, a growth of 16% over quarter 4 FY '23. PAT was at INR 25 crores, a growth of 22% over quarter 4 FY '23. As of FY '24, there is a shift in our business mix with our rating to non-rating ratio now standing at 90:10 compared to 94:6 in FY '23. The shift comes on the back of the ratings segment growth of 14%, while the increasing contribution is witnessed from the nonratings businesses.
A notable aspect of our performance lies in our investment in subsidiaries. While these entities are demonstrating promising growth reflected in the top line figures, that the analytics division of our subsidiary has shown more than 100% growth over a small base of last year on the top line by investing in people, products and technology and operating at a similar loss as compared to the last year.
The Advisory & Consulting division has actually shown more than 65% growth on the top line and becoming marginally profitable. However, we remain optimistic about the trajectory of our nonrating subsidiaries. As we continue to mature and generate profit, we anticipate a corresponding improvement in our consolidated EBITDA percentage over time. This underscores our commitment to measuring long-term value creation and reinforces our confidence in the strategic direction we have charted for sustainable growth.
I would like to now touch upon some key initiatives taken to diversify our business offerings. Our subsidiary, CARE ESG Ratings Limited shall function as an ESG rating provider after having received the approval from SEBI on 2nd May 2024. The CareEdge ESG Ratings will enable the issuers to differ test towards the betterment of its sustainability performance by comparing itself to industry benchmarks and by gauging its relative standing amongst its peers. We have been making efforts on the ESG side over a couple of years, and we believe that with this approval to operate as an ERP, we shall be able to provide value addition to the users of such rating.
CareEdge shall offer Sovereign Credit Ratings and Global Scale Rating of Debt Securities through its entity incorporated in IFSC Gift City. We believe that with the inclusion of India's back in the global bond indices, it will enhance the fund flow into the country, thereby creating opportunities for such ratings.
Our subsidiary CARE Ratings Africa Private Limited has signed MoU with the African Peer Review Mechanism, APRM, in the area of credit rating. Optimistic on the growth potential in this new business line and look forward to their contribution in the growth of CareEdge group. As a part of our transformative journey, we have invested tremendous effort in enhancing and automating the rating processes and improving efficiencies across our organization function.
Our aim of becoming a tech-driven hub remains unwavering and we'll continue to invest in our people, technology, branding and growth initiatives to achieve this goal. CareEdge is exploring ways to leverage large quantum of data and apply the lever of generating AI to enhance the analyst productivity. We are also exploring the new phase of AI in strengthening of our internal control.
Lastly, I would like to highlight some of our ESG achievements and commitments. Recover process in [ backward ], CareEdge Ratings were able to reduce its energy intensity per employee by 8% on a Y-o-Y basis. Our scope 1 and 2 initials declined by 13% on a Y-o-Y basis. CareEdge Ratings average gender diversity was maintained at a healthy level of 40%. CareEdge has formulized the policy and commitment to be a digital opportunity providers as an organization.
I thank you all for your continued support and appreciate the contribution from my colleagues and the entire team at CareEdge for their continued hard work. I can now open the floor for the question-and-answer session.
[Operator Instructions] The first question is from the line of Rajiv Mehta from Yes Securities.
Congratulations for strong results in the year gone by. Sir, I have 2 questions, firstly on domestic ratings business. So there has been slight moderation in the domestic rating revenue growth in Q4. Is it largely reflective of the moderation witnessed in the bank rate growth to NBFCs because of risk rate changes? And was our market share stable? Or is it improving? Can you comment on this?
Thanks, Rajiv. You're right that quarter 4 has witnessed a slight dip as far as the overall growth as compared to the previous quarter. But more or less, we have been able to maintain the trajectory of our growth all throughout the 4 quarters. As you would have witnessed, right from quarter 1 of the fiscal, we have been registering double-digit growth, and we are happy that we were able to maintain it all through the quarters. We do believe that in this kind of an industry, there could be some fluctuations which can potentially happen in some of the quarters. That is why we always emphasize in terms of looking at the things from an annual basis. And we believe that in quarter 4 as well as on an annual basis, we have registered a decent growth.
To your question in terms of the NBFC sector impact, while to some extent, what happens across the segments of the economy, they do have a bearing in terms of how the credit flow to that extend could be happening. But as a full service rating agency having its presence across the segment, we are always prepared for this kind of fluctuation. And because of that, we are able to mitigate what could be impacting one sector by our presence in the other sectors as well.
And broadly, our market share in the overall industry volume, maybe in terms of quantum or in terms of mandate, whether its stable, whether it's moving through [indiscernible].
Yes, Rajiv. So to a good extent, we have been able to improve as far as our market share is concerned, right? And there could be embedded components of looking at it. One of the things that we always look at and in a highly competitive industry, it's always the fact that how much of an incremental rating requirement has been there during the year. And we believe that we have done well on that count in terms of improving our share as far as the incremental number of entities, which would have been rated across the rating agencies, and it would have witnessed all consistently, all the 4 quarters, we have been emphasizing on this aspect that the initial ratings have been driving a significant, I mean they have been giving significant contribution towards poor performance for all the 4 quarters. So we've been able to maintain that thing. So we believe that with the kind of a competitive scenario that we have in the industry, we have done well.
And this question on Ratings segment margin that we report in the segmental pick up, so over the last 2 quarters, the margins have been trending better on Y-o-Y basis. So now we are delivering a better margin. Is it purely a function of operating leverage? Or are there other positive dynamics like the segmental mix or sectoral mix or pricing or maybe incremental wallet share gains, and can you comment on this? And then whether the margins can further go up if the growth were to continue?
Rajiv, this industry is actually a high operating leverage industry, right? So that has a significant impact in terms of how the margins they tend to play out. At the same time, one of the points that you mentioned later in the statement is in terms of the increasing wallet share from across the clientele. That also helps in terms of having certain boost in some of the quarters. But lastly, operating leverage has a significant role to play.
Just one question last on analytics business, where you are very positive on growth. So what underpins your expectations of this sustained strong growth coming, maybe if you can elaborate in terms of our strategy, go-to-market strategy, product and client sourcing plan rotation? And how quickly can we improve margins here because you are making loss. And what can be the eventual level of margins for this business?
Broadly speaking, it has been a case of prioritization of the key areas where we have been working upon as far as the product development is concerned and getting to the GTM stage. So during the year, we reassessed these aspects and identified some products where we could see the market gaining traction on this. And we focus more in terms of getting those products developed faster as compared to the other ones that we were putting our resources. So that has helped in terms of ensuring that the top line growth that we have witnessed from that entity that has improved significantly. Yes, there are losses, and these are difficult businesses to build and grow for the future, but we believe that the kind of traction that we have witnessed in this fiscal, it gives us the confidence in terms of taking the things forward in a much more positive and a stronger manner. Nevertheless, I will also request my colleague, Abhishek, who is leading this vertical to give his comments as well. Abhishek, would you like to say something?
Yes, sure. So as Mehul mentioned, that we have reprioritized a few products and taken some products to market where we feel that the potential for growth is higher, specifically around the credit launching and the credit risk products that we wanted to build and we are good at. So that's something that is driving growth. And we are confident that we will see higher margins as we go forward.
The next question is from the line of Varun Bang from Bandhan Life.
Congratulations for steady performance. So first question is on the rating business. So given our business model, I mean, just like you mentioned, we are a fixed cost business. So what source of business are -- what percentage of business would be -- sorry. How do we look at this business? I mean do we look at it at an absolute basis, or the issue price? Or you look around the yield when you compete with your competitors? And how do you internally think about those assets? And if you can just talk about the competition, let's say, if it is looking at the fixed price, how would we change our stance there?
Varun, can you slightly elaborate on the fixed cost aspect and the deals that you mentioned. What exactly you're trying to understand from us, would you slightly elaborate, please?
So I'm just trying to understand the competitive dynamics in the rating business. So when we compete on a few mandates on the rating side, do we look at the absolute issue price? Or you think about the yields when you give a quotation. How do you internally think about those aspects?
This is, in our case, let's say, in our kind of an industry, this is a combination of all aspects, right? So especially if we are looking at the things from the perspective of what is the quantum that we are going to rate and at what price. We also have to factor in that with whom are we dealing in the sense that if it is -- still existing client, I mean in that case, there always is a high operating leverage component, which gets into that, right, as compared to -- because the efforts that we have to put in when we are dealing with a new client as compared to an existing client, they tend to defer and corresponding to the margins also, they tend to differ on that count.
But in a broader sense, the rating agencies, the pricing is linked to the overall quantum of the debt side to be rated, right? So from that perspective, there is a certain element of stability on those accounts. Nevertheless, the focus on -- in terms of increasing the wallet share and in certain areas, in certain segments, they have their own dynamics when we build it -- which we build up into our pricing on those accounts.
And secondly, on the African subsidiary, how long will it take to establish our presence in Africa? And how do you think it should pan out because it is all about gaining confidence of investor community and I think that would take some time. So how are we thinking about moving there? What kind of a groundwork do we need to do before we establish our presence? And lastly, over 3 to 5 years, what is the reasonable expectation in terms of revenues in Africa?
I think the African business has to be -- African business has to be looked from a slightly different perspective. See, when you are mentioning about subsidiary, it's not just a question of one subsidiary. Today, we are having 2 subsidiaries in Africa. One is already up and operating, right? The other one is just established and where we are awaiting the regulatory license.
So if we are first talking about the subsidiary, which is already operating since 2015 now, it has been already a profit-making proposition for us. And it's a profit-making dividend-paying entity for us. And largely the value creation that we have done by investment in that subsidiary, that is substantial for us, right? And from that angle, another aspect is that when we have established a subsidiary in South Africa, which is a step-down subsidiary for us -- for the parent company, the entire investment in South African subsidiary is also done by demolition entity, which is our direct subsidiary. So from that angle, it has been able to take care of all its expansion plans over there.
Yes, the South African subsidiary that we have established, the license is under processing by the regulator. And while it could be difficult in terms of [indiscernible] I guess on the exit time line by which the regulator shall process the license. But our expectation is that in the first half of the current financial year, we should be getting the license from the regulator. So if you alluded to these 2 subsidiaries, then this will be the perspective from my side.
Got it. And any expectation in terms of revenue in those 2 subsidiaries put together over the next 3 to 5 years?
I believe that the South African subsidiary, while it shall be expected to start the operations during the current financial year, in the initial stages, it would be taking some time to stabilize just as our Mauritian subsidiary did, right? Because in this kind of market, it is also a fact that the ratings are not mandatory in that sense, right? It's the creation of the market that we need to do over there.
In Mauritius, we have successfully displayed our capability in terms of creating the market. And in this process, we have grown quite good over there. And from the perspective of how the overall trajectory would be, I believe that this subsidiaries shall see a good potential for South Africa, especially the overall bond market size is fairly significant, right? So from that perspective, having been getting our presence over there for the future should over well because of the sheer size of the overall market as compared to Mauritius. So we are confident in terms of the growth in these businesses. It will not be possible for us to give any specific number if you're asking for the next 5 years, but we believe that the success that we have demonstrated by value creation in Mauritius, we should be able to take it to our South African venture as well.
Okay, sure. And on the nonrating side, if you can just give a sense of what kind of mandates are we getting in and it is an advisory subsidiary. And what is our sustainable advantage in those mandate products, specific comments would be helpful.
See, both these divisions of our subsidiary, CARE Analytics and Advisory, the Analytics division and the Advisory Consulting division, and principally the mandate to over there is contingent in terms of the entire product offering. So turning first as far as the Analytics division is concerned, largely the clientele is in the BFSI segment. So principally, the mandates that we have got during the year are from the banking and financial institutions as well as the NBFCs, both in India as well as outside India.
As far as our Advisory Consulting business is concerned, the mandate basis the entire product mix that they are having in terms of corporate advisory, in terms of research, in terms of the ESG advisory, so that is across the segment of the corporate landscape such in terms of the large corporates, we have also got from the mid-corporate, we have got from the financial institutions. So it's across the strata of the offering, this is the kind of a full bouquet of advisory service that we are providing. So largely the clientele is emanating from this segment.
Mr. Varun, I request you to rejoin the queue for your follow-up questions. The next question is from the line of Sahil Doshi from ThinqWise Wealth Managers LLC.
A question pertains to the non-rating results. I think this quarter, we've seen a fabulous monetization of pickup in revenue momentum. How are the expenses continue to increase? We see almost INR 6 crores worth of EBITDA loss and other expenses of INR 10 crores versus INR 5 crores. So could you caution me...
Sorry to interrupt Sahil, you are not audible. Can you repeat your question once again?
My question particularly related to non-rating business. I think if I see from Q3 to Q4, the other expenses have increased from INR 5 crores to INR 10 crores, with almost a INR 5 crore increase as the revenue increase is around INR 3 crores sequentially. So could you possibly explain what is happening in the non-rating side because you've already committed more than INR 50-odd crores to the risk solution business. And directionally we're not seeing any signs of cost rationalization or profitability. So could you give us a direction of a 2-year, 3- year perspective that when do we expect to breakeven? What are the kind of products which are in pipeline? And when do we start seeing a real benefit of the same?
I have my colleague, Jinesh, who is our CFO, who will take this question. Jinesh?
Sahil, as mentioned that we are developing various products for the company. So the certain products which are on the research phase are putting in a P&L, for which we'll get a benefit for a longer duration. As you mentioned that there are certain 2 products which are already [ they stay ] on go-to-market stage. So for those products, certain expenses were incurred for developing the product, which qualified as a research cost, which cannot be capitalized, are put in the P&L. That is why if you see our expense -- other expense has gone slightly higher compared to the previous year.
Sir, could you quantify this number? Because of INR 5 crore increase quarter-on-quarter -- and in the previous interaction, you said that this year will be the peak year of investment, whereas in fact, the expenses have only increased materially.
It will be difficult to quantify the differential between all other expenses. But on the approximately around INR 2 crores would be the research cost for this product, which are already on the live stages and certain products will go live in the next year. So both have been considered this year because they are already in the process of development.
Okay. And the other question which I asked given how many products are in development and monetization phase? And in the next 2 years, what is the road map because we've already committed around INR 50-odd crores, in fact, there has been a change in the management also is what I understand. And it becomes very difficult for our investors to understand how much capital will be further allocated to this business, because we are not seeing any signs of reduced profitability coming through.
So there will be 2 products largely which will be popularizing this, because that is from, I think, next March. So that is one. And as you mentioned that we have selected a certain product mix, which we will focus on based on the market requirement. And in a couple of years, we see that we will be breakeven for this entity as well.
Nevertheless, I would like to have the perspective directly being given by Abhishek, who is leading this business. Abhishek, over to you.
So as Jinesh mentioned, I think there are 2 main areas that we are focusing on, one is the credit risk management and other is the credit monitoring phase. And our products are getting built in this area, and we see a lot of traction coming from banks in India and the neighboring countries. So we are very confident that our focus in these areas is going to yield results very soon, yes.
And just a related question in terms of capital allocation. How do we really see the allocation towards all these new initiatives because you've already committed large amounts of money. Is there a time line until which we will commit more funds to these initiatives before we decide to further invest? And second, on the cash which we are continue to build up on balance sheet, the dividend payout compared to the cash which we have has been surpassed. So any thoughts on these 2 aspects?
Actually, you're right that the capital allocation to the nonrating business has been one of the major chunks as far as our investments are concerned. We believe that this business is they were required to be built as far as their importance for the overall derisking at the corporate level at the group level as far as the concentration of the revenue profile is concerned. Yes, it has taken time, and we are not denying that aspect. And we are corresponding to [ kind of ] in terms of stating also that these are difficult businesses which shall be required, but they are important from a diversification perspective, and we remain committed to that.
Having said that, we are absolutely conscious of the fact that the breakeven in this business, principally the risk solutions business, our analytics business, that is something which is of paramount importance. And how best and how early we will be able to get that, that is the absolute priority of the management. And that is why all the actions that we have been taking in this regard, they are quite oriented towards that.
At the same time, let me also be in this aspect that the other division over there, the Advisory Consulting division has indeed reported a marginal profit as compared to the last -- over the last 2 years. So the point is that at times you have to be patient with these businesses to gain traction, right? At the same time, you cannot lose the focus as far as profitably the assets are concerned. So we believe that and we are also quite conscious of the fact, working closely with the management of those subsidiaries to ensure that over a period of time, the investment from the parent company set have to taper down, right? And that is an absolute focus in the CARE for the management over there. There cannot be any second opinion on that, right? And so that's a significant focus, which is going from our side on that. And we believe that the traction that we have started getting now should lead to further sustainment and momentum to be created over there.
No, I appreciate your candid responses. Anything on the capital allocation related to the cash on balance sheet and increased dividend payout or buyback?
Yes. Sahil, see as we have been articulating our position in the previous years as well to the position of the buyback, all the solutions which we have been getting from the investors, the call from any resources, they are indeed put up for -- through the Board, passed on to the Board for an appropriate consideration. And all capital allocation set for us is the options before the Board, we are quite intensely looked upon. And at appropriate time, the board feel there could be a decision in this regard, but it's entirely the prerogative of the board for this. But irrespective of a buyback or a dividend payout, we believe that the capital appreciation for our shareholders. We believe that through our performance, we have been able to create that thing and to that extent our future endeavor also shall be that all the initiatives that we are taking should be generating the right kind of a value creation for all of our stakeholders.
And just a request, if we can give a little more disclosures on the nonratings business, it will be very helpful.
[Operator Instructions] The next question is from the line of [indiscernible].
Just wanted to understand that you provide a rating stability metrics in your presentation. What -- I mean -- and if you look at that metrics, I mean, if you look at the different buckets that you are showing over there, does it imply that your -- basically first thing is that your rating stability is higher than peers and the other thing is that the BB and B categories, you are way higher than peers. Is that the right understanding?
Rating stability has to be looked at from the perspective of -- the ordinality for each kind of rating categories. So it is expected that higher the rating category, the overall stability in those segments should be higher, right? So as we move from AAA lower down the line and our stability is depicted against the trend line of the industry average, right? So from that perspective, the rating performance has to be looked at.
So the ordinality, which I am again emphasizing is that the higher rating categories should be displaying a greater stability and on an overall basis, the investment with ratings should also be continuing to display a greater stability, right? So from this perspective, the rating performance has to be tracked consistently and with an overall philosophy of the quality-led growth. So the focus remains absolutely that all the investment with rating, as we should be very diligent about and vigilant as far as the future trajectory is concerned. Nevertheless, I will also request my colleague, Sachin, who is the Chief Rating Officer, to give his perspective on the rating stability. Sachin, do you would like to add something?
Yes. So yes, as Mehul was mentioning, we have a fairly high rating stability. On that chart, I would like to focus on 2 points. One, we have given a trend of how we have improved in the current -- the more recent 5-year period than the earlier 5-year period. So there, if you will notice, both in A, AA and AAA all 3 rating categories our rating stability has improved. Rating stability essentially means that how many -- for 100 ratings in a given category. So for 100 outstanding AAA rating, what percentage of rating did I move away from AAA in case of AAA can only be a down grade. So that number, which was 97.7% for the last period, 5 years, from the recent 5-year period, which is 2020 to 2024, the number is 98.2%, so it's improved. Similarly, it's improved from A and AA categories also...
Absolutely appreciate that point. As far as what you're saying is that 5,000-odd you have improved the rating stability. My question is basically just that since you -- in the entire average covered is below your stability. Are your ratings more stable than competition. That is as per the data you have compiled in that, but we are very -- especially in BB and B, we are having a huge lead on the rating side on rating stability. Would we be right in summarizing that from this gap?
So you're right. So across the rating categories, the stability of our ratings is superior than average. And yes, you are right, the gap is wider, as you've correctly noticed in BB and BBB category as well.
So does this reflect in any pricing power or any sectoral area where we have any pricing power compared to peers because of this majority that we have in the stability rates?
Pricing and stability not related in any manner. So this is purely a pure self-performance of the predictive capability of the ratings, which have been [ ascend ] and in correlation to that and how the movement of the rating is there. Pricing doesn't come into the picture in any way.
Yes. Just a basic intuitive understanding would be that if the rating stability is high, that means the rating product, there is a higher quality and generally a higher quality product should get a pricing power, but you are saying that, that too is not the way it is looked at.
Does not necessarily work out that way, Devam, that the AAA and AA category would mean that the pricing in that category would be definitely be higher. Only thing which generally would be there that as compared to, say, a BB category comes mid-corporate, when the size of the debt, which has been rated could be on the lower side. But in case of a large corporate, where the size of the debt, which is rated could be on the higher side, that is the only difference which comes into the play. But per se, pricing as a parameter in rating stability, there is no direct correlation.
And can one say that if the overall market grows more and also if you can give cues on -- I mean, how the whole private periods market has fared in the last 1 to 1.5 years, and what would be your outlook for the coming 1 to 3 years? And over there, if that private market grows more than one should be able to see some more pricing power coming in?
See, as the private CapEx and the private market, the overall bond market, they develop and continue to do well. It definitely augurs well for the top line rating agencies, right? So there is always a greater revenue in terms of having a good share of the overall growth in the market. So from that perspective, yes, that if the private players, if they go for more market related borrowings and top rated agencies, they tend to benefit out of it.
And if you can share any flavor on what kind of [ price ] you're seeing over there right now?
Sorry, to interrupt. I request you to rejoin the queue for your follow-up questions.
Sir, just this part, which is connected to the current question. If you can see -- if you can just put some flavor, I would definitely, [indiscernible] that's all.
Product CapEx has been eluding us for some time now, right? But as I mentioned in my opening remarks as well, since the average capacity utilization in the manufacturing sector is now at a level, but ideally, basis the past data, it should be reflective of the CapEx cycle kicking in. We believe that it should be a matter of time before it happens. The fact that it has not happened is also a reality that is not impacted as far as our growth is concerned. But certainly, as and when it picks up, it would be -- definitely be a good thing as far as the industry is concerned. But at the same time, let's also not turn our attention from what the global developments are, all the geopolitical developments and the uncertainties which are there, which definitely hover over the mindset for any corporate before they are committing themselves to a substantial investment. So these aspects, we also have a role to play in the decision of the corporate to ultimately go for a significant investment as far as their future capacities or diversifications are concerned.
So all in all, yes. To the basic question, if private sector capital expenditure kicks in to the expectations that everybody is having, and certainly, yes, the industry is likely to benefit out of it.
The next question is from the line of Parikshit Gupta from Fair Value Capital.
My only question is to understand, I believe the Finance Ministry has manifesto of having domestic Sovereign Credit Rating Agency. Just wanted to hear your comments on that part.
I think the -- as far as we are concerned, our decision is based on our assessment of the opportunities that we need to pay. When we decided to go in as far as Sovereign Ratings are concerned, it was clear in our mind that there is a space which can get created and which needs to be filled by an institution domestically, right, because it also has been the domain of the global rating agencies. So we have the conviction in terms of taking that step and we believe that we have taken the right steps until now. And we are already on -- at a stage where the company is already incorporated. So per se, as far as the government could be having its own priorities and the decision-making, policymaking things which could be correlated to this, but that does not have any direct correlation as far as we, as a commercial independent entity, to decide our future course of action.
The next follow-up question is from the line of Rajiv Mehta from Yes Securities.
So sir, my question is on this approval we've got for ESG ratings from the regulator. So in terms of time line, when do we launch it, what is our linear in terms of product team, what will be the strategy, and then what can be the revenue potential, and then not immediately, but in the next 2 years that we can be looking at?
Rajiv, first, personally foremost thing is that the ESG rating license that we have got very recently, that is on 2nd of May, we have received this thing, right? So -- but the license is already there, and we already have a team in place. And now it's a question in terms of taking the next step in terms of getting the mandate and going there with us. So we believe that very soon we should be able to operationalize it from the angle of actually assigning the ratings on this. So our teams are already working on this and we have been taking this groundwork preparing the necessary infrastructure, having the right kind of analytical team, right kind of the management team over there, all those steps have already been taken even before the license was issued to us. So from that perspective, we are fully ready. And now it's all up to our business as of [ front end ] teams to get the mandates and we should be ready in terms of actually attending those rating.
Nevertheless, I will also be having my colleague, Rohit, who is leading this business. And before I hand over to him, the kind of products which you mentioned or you asked for, so these products in this regard would be the ESG core rating, there is a transition rating, there is combined ratings or the products which have been dependent explicitly by the regulator, what an ERP can provide all these products, they are going to be provided by us. Let us also be clear that as we talk, these ratings are not mandatory per se. It is at the discretion of the corporate how to go about it. But to give a further perspective, it will be good to hear directly from Rohit, also. Rohit, your will.
Thanks, Mehul. And Rajiv, not to repeat Mehul's points, but just to say -- reemphasize that we are ready to roll out the ratings. We just have to go to the market and start looking for mandates. And on this front, our strong corporate relationships, which we have developed over the last 30 years will be useful for us because we will be sharing our BD resources with our parent, which is CARE Ratings, and Regulator allows us to share BD resources between ESG Ratings and CARE Ratings. So that definitely is a big positive and a big boost for us. So as the business starts coming in, we are in a place to sign ESG Ratings.
We have 6 products, 3 on the plain ESG Rating side and 3 products are on the core ESG Rating side. These products are mandatorily required to be put out as per the SEBI regulations. So the 3 products that I'm talking of on [ plain vanilla ] 3 products are ESG ratings, transition ratings and combined ratings. Combined rating is combination of ESG rating and the transition rating. And similar 3 products are there on the core ESG side. By core what I mean that SEBI has put out detailed guidelines on BRSR reporting. And BRSR reporting also has one subset, which is called BRSR core. The rating is done on the basis of information obtained from BRSR core parameters will be called BRSR core ratings. So that would be our product control, and we are ready to assign rating across these 6 product categories.
Thank you for this elaborate answer. And just lastly on this, broadly in the next 3 years, how do we see our mix of overall consolidated mix moving between domestic rating and the non-rating put together?
So Rajiv, in the previous interactions, I had mentioned that progressively, we'd like to move towards an 80-20 kind of mix rate with the 20% coming from the non-rating businesses, that's over a period of time. This year, actually, we have reached up to over 10% contribution coming from the nonrating businesses, which was 6% last year. We have made some progress on that. And in the future years we shall be giving a greater focus on this.
And when we are mentioning about this, let's also be clear that everything in this regard, this increased contribution is coming on the back of a sustained growth on the rating side as well. So when the overall pie is increasing, the rating also driving the overall thing, but at the same time, this contribution from [ CAT ] coming from the non-rating businesses, that is also helping. And when I talked about the ratings group, the subsidiaries on the rating side, they have also been contributing and consistently growing. So I think it's an all-round growth that we are talking about.
Just last 1 clarification. Do you also ensure that the overall consolidated margin don't get diluted because of higher share going up from the non-rating segment, maybe right now at the margin, making some profit or making losses, but we don't see that's improving, but overall share going up 5% to 10% will ensure that the overall consolidated margin keeps going up, right?
Yes, the overall consolidated revenue when it goes up -- here, if you're talking about the impact of the increased contribution of the non-rating businesses in terms of suppressing the consolidated margins, we have to be conscious of the fact that every business has their own margin profile, right? So the rating margins per se cannot directly be correlated with an analytic for a consulting advisory here kind of a margin. So ratings generally tend to have a better margin in this regard. But nevertheless, irrespective of that, the effect has to be that over a period of time the contribution of the non-rating businesses if it increases at a group level that outpace well in terms of withstanding any kind of a fluctuation, which potentially could be impacting any of the businesses, right? So it has to be a look from a larger angle, but some impact because of an increased contribution it cannot be wished away, considering the fact that the businesses are entirely different.
The next question is from the line of [indiscernible].
Yes, sir, can we share the total revenue, EBITDA and debt for the Africa-Mauritius entity for FY '24?
FY '24, anyhow, once the annual report is disclosed, you will get the greater details. But in a broader sense, Jinesh, can you give a broad perspective?
For Africa,, it is -- the revenue is around INR 10 crores. And the PAT margin is around 30% -- 35% PAT margin for Africa.
And what would be the current market for ESG practice generally and what potential do we see there in terms of numbers? We understand, obviously, that it's a great diversification, but also what to be the current market and what potential do you see that in terms of numbers over the next 2 to 5 years?
See, when you're talking about ESG practice per se, that's largely related to our consulting advisory business, right? ESG rating is different, ESG practice in the consulting advisory is different, right? So let me just bring in my colleague, Swati, who has consulting advisory pays along with the ESG advisory to give your perspective on this. Swati, are you there?
Yes. So essentially, if you really look at it the way ESG advisory business is growing, it is very difficult to say a number because different elements are getting added to it, primarily driven by the regulatory business, the customer requirement, which could be both nationally or in the international market and the requirements in the supply chain. So essentially, if you really ballpark numbers, if you really look at it, who are the bigger players are obviously the big 4, and then there are a lot of these other agencies also. So the market can be anybody's guess in that sense.
If you break it down into various segments and say, okay, BRSR reporting or generally reporting segment in ESG integration segment, then you can still have some kind of concrete numbers. So from that perspective, I mean, we at CareEdge Advisory, we are very well positioned. If you really look at our practice, we've grown by more than 100% over last year. We are very well positioned across all the value offerings that we have in the ESG advisory space. And we will be continuously receptive to the changes in the market and continue to keep evolving ourselves in terms of our capability as well as our delivery tactics and the delivery outcomes to meet the challenges and the needs of this market. I hope that answers.
Thank you very much. That will be the last question for the day. I would now like to hand the conference over to Mr. Mehul Pandya, Managing Director and Group CEO, for closing comments. Thank you and over to you, sir.
I would like to thank everyone for joining this call. I believe that and I hope that we have been able to address your queries. For any information, you can get in touch with our team at the company level or can have you contact SG, our strategic growth advisors who are our Investor Relations advisors as well. Broadly speaking, I believe that and reemphasizing on the aspect that the trust and faith of the investors that you report in us all through and the support that we have got, that has given us a lot of confidence in terms of taking new initiatives than -- in the process over a period of time, work towards creating better stakeholder value creation. So thank you so much for joining this call and wish you all the best.
Thank you. On behalf of CARE Ratings Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines. Thank you.